According to GlobalData’s medical device pipeline database, 67 Nuclear Imaging Equipment devices are in various stages of development globally. GlobalData’s report Nuclear Imaging Equipment provides an overview of the segment’s pipeline landscape and offers detailed analysis of its products. Buy the report here.

Smarter leaders trust GlobalData

Of these devices, 41 are in active development, while the remaining 26 are in an inactive stage of development. There are 26 products in the early stages of development, and the remaining 15 are in the late stages of development.

Nuclear imaging equipment makes use of radioactive substances (also called as nuclear medicine or radiopharmaceuticals) that are inserted into the body orally or intravenously. Nuclear Imaging systems capture the radiations emitted by radiopharmaceuticals to create images of the structures and activities inside the human body. These images enable physicians to look inside a human body to help determine the cause of an illness or injury and provide an accurate diagnosis. Positron Emission Tomography (PET) systems, Positron Emission Tomography/Computed Tomography (PET/CT) systems, Positron Emission Tomography/Magnetic Resonance Imaging (PET/MRI) systems, Single Photon Emission Computed Tomography (SPECT) systems and Single Photon Emission Computed Tomography/Computed Tomography (SPECT /CT) systems are tracked under this category. One unit refers to One nuclear imaging equipment.

Innovations in the medical devices sector are linked to the development of new approaches, processes, or technologies for treating, diagnosing, and managing disease in response to demand from healthcare for better patient outcomes and reduce healthcare costs.

Based on an analysis of GlobalData’s Medical Intelligence Center pipeline product database, these actively developed Nuclear Imaging Equipment pipeline devices are all expected to be approved within the next ten years.

Currently, private organizations, public entities and institutions are working on the development of Nuclear Imaging Equipment devices. Overall, most of these Nuclear Imaging Equipment pipeline devices are being developed by private entities.

Key players involved in the active development of Nuclear Imaging Equipment include Stanford University, Stanford University, Siemens Healthineers, Shanghai United Imaging Healthcare, General De Equipment for Medical Imaging, Philips Healthcare Informatics, Brain Biosciences, SynchroPET, University of California Davis and University of Washington.

For a complete picture of the developmental pipeline for Nuclear Imaging Equipment devices, buy the report here.

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article. 

The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. The Pipeline Products database is a is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.